Literature DB >> 6408185

T cell dependence and factor reconstitution of in vitro antibody responses to TNP-B. Abortus and TNP-Ficoll: restoration of depleted responses with chromatographed fractions of a T cell-derived factor.

J J Mond, J Farrar, W E Paul, J Fuller-Farrar, M Schaefer, M Howard.   

Abstract

In vitro anti-trinitrophenyl (TNP) antibody responses to TNP conjugates of killed Brucella abortus organisms (TNP-BA), an antigen previously designated as a type 1 thymus-independent (TI-1) antigen, are markedly diminished after vigorous depletion of T cells, as are the responses to the type 2 TI (TI-2) antigen, TNP-Ficoll. We, therefore, propose that these antigens be redesignated as type 1 and type 2, respectively, to reflect their T cell dependence but to differentiate them from classical T cell-dependent (TD) antigens. T cell-depleted responses to type 1 and type 2 antigens can be restored by the addition of a) EL4 supernatant, b) phenyl-sepharose-purified fractions of EL4 supernatant that are rich in interleukin 2(IL2), and c) pl 4.5-5.5 isoelectric focused (IEF) fractions of EL4 supernatant which are also rich in IL2 activity. Removal of IL2 activity from EL4 supernatant by absorption on IL2-dependent T cells substantially reduced its restorative ability. Whether the active principle in EL4 supernatant activity responsible for restoring responses to type 1 and type 2 antigens is IL2, and whether it acts directly on B cells or by acting on contaminating T cells, is unresolved.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens.

Authors:  A Zandvoort; W Timens
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

Review 2.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

3.  Selective depression of thymus-independent anti-DNP antibody responses induced by adult but not neonatal splenectomy.

Authors:  D Gray; D Chassoux; I C MacLennan; H Bazin
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

4.  Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice.

Authors:  M Garg; W Luo; A M Kaplan; S Bondada
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Control of B cell differentiation by T cells.

Authors:  J J Mond; M E Schaefer
Journal:  Surv Immunol Res       Date:  1983

6.  Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide.

Authors:  E Moreno; R S Kurtz; D T Berman
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Lipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses.

Authors:  M Betts; P Beining; M Brunswick; J Inman; R D Angus; T Hoffman; B Golding
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Affinity-purified interleukin 2 induces proliferation of large but not small B cells.

Authors:  J J Mond; C Thompson; F D Finkelman; J Farrar; M Schaefer; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  An immunosuppressive murine leukaemia virus induces a Th1-->Th2 switch and abrogates the IgM antibody response to sheep erythrocytes by suppressing the production of IL-2.

Authors:  A Faxvaag; T Espevik; A Dalen
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  Effects of cigarette smoke on the antibody responses to thymic independent antigens from different lymphoid tissues of mice.

Authors:  S N Goud; A M Kaplan; B Subbarao
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.